To do so, we first transfected three commonly used human prostate cancer cell lines (DU145, LnCaP, and PC3) and one murine prostate cancer cell line (Myc-CaP) with the activated form of ERBB2 or H-RAS. This evidence concerns the gene HRAS and prostate carcinoma.